云南白药: directors' dealings · France · AMF

Explore the full directors' dealings record of 云南白药, a listed equity based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €101.3bn. The latest transaction was reported on 17 May 2022 (Purchase). Among the most active insiders: 董明. All data is accessible without an account.